Langerhans cell histiocytosis: A review of the current recommendations of the histiocyte society

Pediatric Dermatology

Volumn 25, Issue 3, 2008, Pages 291-295

  Satter, Elizabeth K ^a   High, Whitney A ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMETHINE; CLADRIBINE; LANGERIN; MONOCLONAL ANTIBODY; PREDNISONE; STEROID; T6 ANTIGEN;

CLINICAL FEATURE; DENDRITIC CELL; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE CLASSIFICATION; HISTIOCYTOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LANGERHANS CELL; MEDICAL SOCIETY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PUVA; REVIEW;

ADULT; AGE FACTORS; CHILD, PRESCHOOL; HISTIOCYTES; HISTIOCYTOSIS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 44949101315     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00669.x     Document Type: Review

References (41)

1. Weitzman S, Jaffe R. Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses. Pediatr Blood Cancer 2005 45 : 256 264.
2. Savasan S. An enigmatic disease: childhood Langerhans cell histiocytosis in 2005. Int J Dermatol 2006 45 : 182 188.
3. Arceci RJ, Longley BJ, Emanuel PD. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program 2002 1 : 297 314.
4. Favara BE, Feller AC. Contemporary classification of histiocytic disorders. The WHO committee on histiocytic/reticulum cell proliferations and the reclassification working group of the Histiocytic Society. Med Pediatr Oncol 1997 29 : 157 166.
5. Chu T, D'Angio GJ, Favara B et al. Histiocytosis syndromes in children. Writing group of the Histiocyte Society. Lancet 1987 1 : 208 209.
6. Broadbent V, Gadner H, Komp DM et al. Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society. Med Pediatr Oncol 1989 17 : 492 495.
7. Schmitz L, Favara BE. Nosology and pathology of Langerhans cell histiocytosis. Hematol Clin North Am 1998 12 : 222 246.
8. Geismann F, Lepelletier Y, Fraitag S et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001 97 : 1241 1248.
9. Hicks J, Flaitz M. Langerhans cell histiocytosis: Current insights in a molecular age with emphasis on clinical oral and maxillofacial pathology practice. Oral Surg Oral Med Oral Path Pral Radiol Endod 2005 100 : S42 S66.
10. Nezelof C, Basset F. Langerhans cell histiocytosis research. Past, present, and future. Hematol Oncol Clin North Am 1998 12 : 385 406.
11. Bechan GI, Egeler RM, Arceci RJ. Biology of Langerhans cells and Langerhans cell histiocytosis. Int Rev Cytol 2006 254 : 1 43.
12. Querings K, Starz H, Balda BR. Clinical spectrum of cutaneous Langerhans' cell histiocytosis mimicking various diseases. Acta Derm Venereol 2006 86 : 39 43.
13. Donadieu J. A multicenter retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' cell study group. Arch Dis Child 1996 75 : 17 24.
14. Stein SL, Paller AS, Haut PR et al. Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series. Arch Pediatr Adolesc Med 2001 155 : 778 783.
15. Longaker MA, Frieden IJ, LeBoit PE et al. Congenital "self- healing" Langerhans cell histiocytosis: the need for long term follow-up. J Am Acad Dermatol 1994 31 : 910 916.
16. Bhatia S, Nesbit ME, Egeler RM et al. Epidemiological study of Langerhans cell histiocytosis in children. J Pediatr 1997 130 : 774 781.
17. Isaacs H. Fetal and neonatal histiocytoses. Pediatr Blood Cancer 2006 47 : 123 129.
18. Alston RD, Tatevossian RG, McNally RJ et al. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatr Blood Cancer 2007 48 : 555 560.
19. Howarth DM, Gilchrist GS, Mullan BP et al. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999 85 : 2278 2290.
20. Gotz G, Fichter J. Langerhans'-cell histiocytosis in 58 adults. Eur J Med Res 2004 9 : 510 514.
21. Arcico M, Girschikofsky M, Généreau T et al. Langerhans cell histiocytosis in adults Report from the International Registry of the Histiocytic Society. Eur J Cancer 2003 39 : 2341 2348.
22. Lahey ME. Histiocytosis-X: an analysis of prognostic factors. J Pediatr 1975 87 : 184 189.
23. Esterly N, Mauer H, Gonzalez-Crussi F. Langerhans cell histiocytosis: a seven-year experience at a children's hospital. J Am Acad Dermatol 1985 13 : 481 496.
24. Gadner H, Grois N, Arico M et al. A randomized trial of treatment for multisystem Langerhans cell histiocytosis. J Pediatr 2001 138 : 728 734.
25. Rivera-Luna R, Martinez-Guerra G, Altamirano-Alverez E et al. Langerhans cell histiocytosis: clinical experience with 124 patients. Pediatr Dermatol 1998 5 : 145 150.
26. Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Clin North Am 1998 12 : 247 259.
27. Ladisch S, Gadner H, Arico M et al. LCH-I: a randomized trial of etoposide verses vinblastine in disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994 23 : 107 110.
28. Gadner H, Heitger A, Grois N et al. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994 23 : 72 80.
29. Minkov M, Grois N, Heitger A et al. Treatment of multisystem Langerhans cell histiocytosis. Results of DAL-HX83 and DAL-HL90 study group. Klin Pediatr 2000 212 : 139 144.
30. Ceci A, De Terlizzi M, Colella R et al. Langerhans cell histiocytosis in childhood: results from the Italian cooperative AIEOP-CNR-HX83 Study. Med Pediatr Oncol 1993 21 : 259 264.
31. McClain KL, Kozinetz CA. A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer 2007 48 : 44 49.
32. Mottl H, Ganevovà M, Radvanská J et al. Outcome of treatment of Langerhans cell histiocytosis to the LCH II protocol. Čas LéK Čes 2005 144 : 753 755.
33. Broadbent V, Gadner H. Current therapy for Langerhans cell histiocytosis. Hematol Clin North Am 1998 12 : 327 338.
34. Arceci RJ, Brenner MK, Pritchard J. Controversies and new approaches to treatment of Langerhans cell histiocytosis. Hematol Clin North Am 1998 12 : 339 357.
35. Munn S, Chu AC. Langerhans cell histiocytosis of the skin. Hematol Clin North Am 1998 12 : 271 286.
36. Kilpatrick SE, Wenger DE, Gilchrist GS et al. Langerhans cell histiocytosis (Histiocytosis X) of bone. Cancer 1995 76 : 2471 2484.
37. Titigemeyer C, Grois N, Minkov M et al. Pattern and course of single system disease in Langerhans cell histiocytosis data from the DAL-HX83 and 90-study. Med Pediatr Oncol 2001 37 : 108 114.
38. McLelland J, Broadbent V, Yeomans E et al. Langerhans cell histiocytosis: the case for conservative treatment. Arch Dis Child 1990 65 : 301 303.
39. Donadieu J, Piguet C, Bernard F et al. A new clinical score for disease activity in Langerhans cell histiocytosis. Pediatr Blood Cancer 2004 43 : 770 776.
40. Haupt R, Naduri V, Calevo MG et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society- Late effects study group. Pediatr Blood Cancer 2004 42 : 438 444.
41. Nanduri VR, Pritchard J, Levitt G et al. Long term morbidity and health related quality of life after multi-system Langerhans cell histiocytosis. Eur J Cancer 2006 42 : 2563 2569.